[Clinical significance of HLA-A, -B, -C, -DRB1, -DQB1 haplotype gene frequencies].

Objective: To analyze family-based haplotype frequencies of HLA-A, -B, -C, -DRB1 and -DQB1 genes and their clinical significance. Methods: The data of HLA genotyping in 3568 families undergoing related haploidentical transplantation between 2012 and 2017 at the First Affiliated Hospital of Soochow University were retrospectively evaluated. The HLA genotyping was performed by PCR amplification with sequence-based typing (PCR-SBT) and sequence-specific oligonucleotide probe (PCR-SSOP) methods. The family genetic analysis and haplotype frequencies were also investigated. Results: All the families were divided into 3 groups, including group1 of 1 422 entire families; group2 of 1 310 patients and either of their parents or one of their children; group3 of 836 patients and their HLA>/=5/10 matched sibling donors. In the haplotypes with frequencies greater than 0.1% in group1+ group2, the frequency of A*11ratio01-B*40ratio01-C*03ratio04-DRB1*11ratio01-DQB1*03ratio01, A*02ratio07-B*51ratio01-C*14ratio02-DRB1*09:01-DQB1*03ratio03 were significantly different between group1 and group2 (P=0.029, 0.033) . The frequency of A*11ratio01-B*46ratio01-C*01ratio02ratio01G-DRB1*09ratio01-DQB1*03ratio03 was significantly different between group1 and group3 (P=0.035) . The frequency of A*02ratio01-B*40ratio01-C*07ratio02-DRB1*09ratio01-DQB1*03ratio03 was significantly different between group1 and group2 (P=0.034) , or group1 and group3 (P=0.034) . The frequency of A*24ratio02-B*13ratio01-C*03ratio04-DRB1*12ratio02-DQB1*03:01 was significantly different between group2 and group3 (P=0.046) . Conclusion: In this study, we summarize the prevalence of haplotype frequencies in terms of HLA-A, -B, -C, -DRB1 and-DQB1. Based on the database of family haplotype analysis, patients and donor candidates are sorted with matched HLA genotype while unmatched HLA haplotype. Even in patients without entire family information, HLA haplotype analysis assists in choosing the optimal related or unrelated donors.